title: Editorial: sprue-like enteropathy due to olmesartan and other angiotensin receptor blockers--the plot thickens.
authors.affiliation: Celiac Disease Center, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. bl114@columbia.edu.
authors.forename: B
authors.initials: B
authors.lastname: Lebwohl
authors.forename: J F
authors.initials: JF
authors.lastname: Ludvigsson
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D003625:Data Collection; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced* / Q000453:epidemiology*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008297:Male; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D007093:Imidazoles; D013777:Tetrazoles